MB "Biomedicininės konsultacijos" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
15,370 |
- |
179 |
170 |
- |
0.08 |
0.00 |
100.00 |
1.11 |
2,219 |
9 |
1,012 |
1,216 |
2022 |
---|
8,535 |
- |
74 |
70 |
- |
0.07 |
0.00 |
100.00 |
0.82 |
2,288 |
4 |
1,699 |
593 |
2023 |
---|
11,710 |
- |
119 |
113 |
- |
0.13 |
0.00 |
100.00 |
0.96 |
2,401 |
8 |
918 |
1,491 |
Register and
explore Okredo data2023 |
---|
11,710 |
- |
119 |
113 |
- |
0.13 |
0.00 |
100.00 |
0.96 |
2,401 |
8 |
918 |
1,491 |
Register and
explore Okredo data2023
Turnover (€)
11,710 €37 % *
Sales per employee (€)
-Profit before tax (€)
119 €61 % *
Net Profit (€)
113 €61 % *
Profit per employee (€)
-Working capital requirement
0.13 85.71 % *
Debt-to-equity ratio
0.00 - *
Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
0.96 %17.07 % *
Equity (€)
2,401 €5 % *
Amounts Payable And Liabilities (€)
8 €100 % *
Non-current Assets (€)
918 €-46 % *
CurrentAssets (€)
1,491 €151 % *